Lv5
870 积分 2024-03-09 加入
OP16 Serious infection in Inflammatory Bowel Diseases patients treated with vedolizumab, ustekinumab, JAK inhibitors, anti-TNF or aminosalicylates
2个月前
已完结
ECCO Guidelines on Therapeutics in Crohn’s Disease: Medical Treatment
2个月前
已完结
Serious infection in inflammatory bowel diseases patients treated with vedolizumab, ustekinumab, JAK inhibitors, anti-TNF or aminosalicylates
3个月前
已完结
Long-term effectiveness and safety of ustekinumab in patients with Crohn’s disease: real-world evidence
3个月前
已完结
Real-world Short-term Effectiveness of Ustekinumab in Crohn’s Disease: Results from a Multicenter, Prospective Study in China
3个月前
已完结
Short-Term Effectiveness of Ustekinumab in Crohn’s Disease: Results from a Real-World Retrospective Multicenter Study in China
3个月前
已关闭
Ustekinumab en enfermedad de Crohn: efectividad y seguridad en práctica clínica
4个月前
已完结
Comparative efficacy and safety of biologic therapies for moderate-to-severe Crohn's disease: a systematic review and network meta-analysis
4个月前
已完结
Efficacy and Safety of Ustekinumab and Vedolizumab for Crohn’s Disease of the Pouch
4个月前
已关闭
S902 Intestinal Ultrasound Response and Transmural Remission After 48 Weeks of Treatment With Ustekinumab in Crohn’s Disease: STARDUST Trial Substudy Results by Line of Treatment and by Location
4个月前
已关闭
皖公网安备34019202002308
